By Robert PreidtHealthDay Reporter WEDNESDAY, Dec. 15, 2021 (HealthDay News) — COVID-19 vaccination provides far less protection to people with multiple myeloma than to survivors of other types of cancer, new research shows. The findings highlight the need for multiple myeloma patients “to be especially careful — to take social distancing seriously and utilize masking … Read more
Multiple myeloma is a rare type of blood cancer that affects less than 1% of Americans. It can take a serious toll on your life. But better treatments and more awareness of the disease bring power and hope. And a diagnosis doesn’t mean you have to put your life on hold. Here are … Read more
If you or a loved one has just learned they have multiple myeloma, the diagnosis may come as a surprise. Chances are that you don’t know much — if anything — about this type of cancer, so you’ll likely have a lot of questions for your doctor as you take in the news and begin … Read more
SOURCES: Amy Pappas, myeloma patient, Cleveland, OH. Keith Guernsey, myeloma patient and coach, Gainesville, GA. Urvi Shah, myeloma specialist, Memorial Sloan Kettering Cancer Center, New York City. Jason Valent, myeloma specialist, Cleveland Clinic, Cleveland, OH. Michelle O’Hare, oncology/myeloma nurse, Memorial Sloan Kettering Cancer Center, New York City. Cancer.Net: “Multiple Myeloma: Types of Treatment.” Healthtree. Multiple … Read more
Dec. 9, 2020 — For patients with heavily-pretreated multiple myeloma, the strong responses seen with the new (CAR T-cell treatment ciltacabtagene autoleucel (cilta-cel) have also been prolonged, according to investigators in the CARTITUDE-1 trial. Among 97 patients with multiple myeloma whose cancer got worse while on three or more prior types of treatment or … Read more
SOURCES: cancer,gov: “Stopping Multiple Myeloma with New Treatments” cancer.gov: “Pomalidomide for Multiple Myeloma” Cancer.gov: “Drugs Approved for Multiple Myeloma” cancer.gov: “New Use for Lenalidomide in Multiple Myeloma” Hans C. Lee, MD, University of Texas MD Anderson Cancer Center. Blood: “Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.” FDA: … Read more